Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma
NCT00816855
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
docetaxel, cisplatin, fluorouracil
Sponsor
Fudan University